In the study of solid tumor models, the delivery of anti-VEGF siRNA and anti-PD-L1 siRNA can inhibit the expression of corresponding proteins, restore the anti-tumor function of T cells, and inhibit the growth of new blood vessels. Here, VEGFA is linked to neoplasm.